Researchers included 96,486 participants in the study. Upon hospital admission, 37.8 percent of patients had an active outpatient prescription for a statin and 59.5 percent used moderate to intensity dosing. Of this cohort, 31.5 percent had exposure to the statin on the day of or day following surgery.
Here are four highlights:
1. Among patients exposed to stains, researchers noted a significant reduction in 30-day all cause mortality.
2. Researchers also noted a substantial link between lower risk of complication and exposure to statin.
3. Based on these findings, the researchers concluded that “early perioperative exposure to a statin was associated with a significant reduction in all-cause perioperative mortality and several cardiovascular and non-cardiovascular complications.”
4. The study’s limitations includes the potential for selection biases in the aforementioned results.
More articles on quality & infection control:
ProPublica: 10 drugs with the highest physician payments from companies
The Joint Commission addresses confusion surrounding provider text messaging: 5 things to know
Nurses claim No. 1 spot for most trusted profession for 15th consecutive year
